Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database-Reference-Cited by-同舟云学术

Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database

Published:2024-03 Issue:3 Volume:42 Page:69.e17-69.e25
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Porreca Annamaria^ORCID,Di Nicola Marta,Lucarelli Giuseppe^ORCID,Dorin Vartolomei Mihai,Soria Francesco,Terracciano Daniela^ORCID,Mistretta Francesco Alessandro,Luzzago Stefano,Buonerba Carlo,Cantiello Francesco,Mari Andrea,Minervini Andrea,Veccia Alessandro,Antonelli Alessandro,Musi Gennaro,Hurle Rodolfo,Busetto Gian Maria^ORCID,Del Giudice Francesco,Ferretti Simone,Perdonà Sisto,Prete Paola Del,Porreca Angelo,Bove Pierluigi,Crisan Nicolae,Russo Giorgio Ivan^ORCID,Damiano Rocco,Amparore Daniele,Porpiglia Francesco,Autorino Riccardo^ORCID,Piccinelli Mattia,Brescia Antonio,Tătaru Sabin Octavian^ORCID,Crocetto Felice^ORCID,Giudice Arturo Lo,de Cobelli Ottavio,Schips Luigi,Ferro Matteo,Marchioni Michele^ORCID

Publisher

Elsevier BV

Reference32 articles.

1. Long-term outcomes of outpatient laser ablation for recurrent non-muscle invasive bladder cancer: a retrospective cohort study;Grover;BJUI Compass,2021

2. Active surveillance for recurrent non-muscle invasive bladder cancer: which lessons have we learned during COVID-19 pandemic?;Paciotti;Minerva Urol Nephrol,2022

3. Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study;Ferro;Minerva Urol Nefrol,2021

4. Nomogram predicting bladder cancer-specific mortality after neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: results of an international consortium;Mir;Eur Urol Focus,2021

5. Survival outcomes after immediate radical cystectomy versus conservative management with Bacillus Calmette-Guérin among T1 high-grade micropapillary bladder cancer patients: results from a multicentre collaboration;Lonati;Eur Urol Focus,2022